Want to see AKTS full AI Analyst Report?
Technical Sentiment
Overall Consensus
Buy
11Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
8Bullish
0Neutral
2Bearish
Aktis Oncology, Inc.’s (AKTS) Moving Averages Convergence Divergence (MACD) indicator is 0.46, suggesting Aktis Oncology, Inc. is a Sell.
Aktis Oncology, Inc.’s (AKTS) 20-Day exponential moving average is 25.02, while Aktis Oncology, Inc.’s (AKTS) share price is $26.92, making it a Buy.
Aktis Oncology, Inc.’s (AKTS) 50-Day exponential moving average is 24.38, while Aktis Oncology, Inc.’s (AKTS) share price is $26.92, making it a Buy.
Aktis Oncology, Inc. (AKTS) Pivot Points
Classic
24.80
25.48
25.83
26.50
26.85
27.53
27.88
Fibonacci
25.48
25.87
26.11
26.50
26.89
27.14
27.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Aktis Oncology, Inc. (AKTS) Moving Averages
MA5
26.23Sell
25.89Sell
MA10
25.40Buy
25.49Buy
MA20
24.54Buy
25.02Buy
MA50
25.65Buy
24.38Buy
MA100
22.61Buy
23.17Buy
Aktis Oncology, Inc.’s (AKTS) 10-Day exponential moving average is 25.49, while Aktis Oncology, Inc.’s (AKTS) share price is $26.92, making it a Buy.
Aktis Oncology, Inc.’s (AKTS) 100-Day exponential moving average is 23.17, while Aktis Oncology, Inc.’s (AKTS) share price is $26.92, making it a Buy.
Aktis Oncology, Inc.’s (AKTS) stock price is $26.92 and Aktis Oncology, Inc.’s (AKTS) 50-day simple moving average is 25.65, creating a Buy signal.
Aktis Oncology, Inc.’s (AKTS) stock price is $26.92 and Aktis Oncology, Inc.’s (AKTS) 100-day simple moving average is 22.61, creating a Buy signal.
Aktis Oncology, Inc. (AKTS) Technical Indicators
RSI (14)
55.67
Neutral
STOCH (9,6)
77.38
Neutral
STOCHRSI (14)
77.38
Neutral
MACD (12,26)
0.46
Sell
ADX (14)
20.44
Neutral
Williams %R
-33.06
Buy
CCI (14)
113.21
Sell
ATR (14)
1.49
-
Ultimate Oscillator
52.99
Neutral
ROC
6.97
Buy
Aktis Oncology, Inc.’s (AKTS) Relative Strength Index (RSI) is 55.67, creating a Neutral signal.
Aktis Oncology, Inc.’s (AKTS) Trend Strength Indicator (ADX) is 20.44, creating a Neutral signal.
Aktis Oncology, Inc.’s (AKTS) Commodity Channel Index (CCI) is 113.21, creating a Sell signal.
Aktis Oncology, Inc.’s (AKTS) Price Rate of Change (ROC) is 6.97, creating a Buy signal.
FAQ
Is AKTS a Buy, Hold, or Sell?
Based on AKTS’s technical indicators, AKTS is a Buy.
What is AKTS’s RSI (14)?
AKTS’s RSI (14) is 55.67, which suggests AKTS is a Neutral.
What is AKTS’s MACD?
AKTS’s MACD is 0.46, which suggests AKTS is a Sell.
What is AKTS’s 5-day moving average?
AKTS’s 5-day moving average is 26.23, which suggests AKTS is a Sell.
What is AKTS’s 20-day moving average?
AKTS 20-day moving average is 24.54, which suggests AKTS is a Buy.
What is AKTS’s 50-day moving average?
AKTS’s 50-day moving average is 25.65, which suggests AKTS is a Buy.
What is AKTS’s 200-day moving average?
Currently, no data Available
What is AKTS’s Williams % R (14)?
AKTS’s Williams % R (14) is -33.06, which suggests AKTS is a Buy.
What is AKTS’s CCI (14)?
AKTS’s CCI (14) is 113.21, which suggests AKTS is a Sell.